Paracetamol/ Ascorbic Acid/ Caffeine/ Phenylephrine/ Chlorphenamine
Indications
Registered South African indications:
- Relief of symptoms associated with colds and influenza
Boxed warning
| This combination product contains paracetamol which may be fatal in overdose. In the event of overdosage or suspected overdose and notwithstanding the fact that the person may be asymptomatic, the nearest doctor, hospital or poison centre must be contacted immediately |
Contraindications (ZA)
Registered South African contraindications
- Hypersensitivity to the active ingredient or to any of the excipients in this combination product
- Coronary disease
- Hypertension
- Cardiovascular disease
- Hyperthyroidism
- Epilepsy
- Pregnancy
- Persons being treated with monoamine oxidase inhibitors or within 10 days of stopping such treatment
- Prostatic enlargement
- Paralytic ileus or pyloric stenosis
- Closed angle glaucoma or with a narrow angle between the iris and the cornea
- Not recommended for children under the age of 6 years
Warnings & precautions
South African recommendations
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
Excess doses
- Dosages in excess of those recommended may cause liver damage. The patient should not use continuously for more than 10 days without consulting a doctor
Drowsiness and impaired concentration
- This combination medicine may lead to drowsiness and impaired concentration, which may be aggravated by the simultaneous intake of alcohol or other central nervous system depressant agents
Contains lactose monohydrate
- Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine
May affect the ability to drive and use machines
- Patients should be warned not to drive a motor vehicle, operate dangerous machinery or climb dangerous heights, as impaired decision making could lead to accidents
Paracetamol
Excess doses
- Dosages in excess of those recommended may cause severe liver damage. Patients suffering from liver or kidney disease should take paracetamol under medical supervision
Severe cutaneous adverse reactions (SCARs)
- Severe cutaneous adverse reactions (SCARs) such as toxic epidermal necrolysis (TEN), Steven-Johnson syndrome (SJS), acute generalised exanthematous pustulosis (AGEP), eosinophilia and systemic (DRESS)/Drug-induced hypersensitivity syndrome (DIHS) and fixed drug eruptions (FDE) have been reported in patients treated with paracetamol containing medicines. If a patient develops SCAR, treatment with this combination medicine must immediately be discontinued and appropriate treatment instituted
Caffeine
History of peptic ulcers
- Caffeine should be given with care to patients with a history of peptic ulcers
Phenylephrine
Hypersensitive patients
- Administer with caution to hypersensitive patients, particularly those with hyperthyroidism, patients with cardiovascular disease, diabetes mellitus or closed angle glaucoma
Chlorphenamine
Sedation
- Chlorphenamine may produce sedation, persons should not operate machinery, drive cars, climb dangerous heights or perform potentially dangerous tasks where impaired decision making could lead to accidents
Adult dosage (ZA)
Forms avail. in SA and covered in this monograph: cap
South African registered indications and dosages
Relief of symptoms associated with colds and influenza
- Such as nasal congestion, sniffing, headache, minor aches and pains
Paracetamol/ Ascorbic acid/ Caffeine/ Phenylephrine/ Chlorphenamine
300/75/30/5/2 (mg)
- Oral (cap): 2 cap, 3 times dly
Paediatric dosage (ZA)
Paed. forms avail. in SA and covered in this monograph: cap
South African registered indications and dosages
Relief of symptoms associated with colds and influenza
- Such as nasal congestion, sniffing, headache, minor aches and pains
Paracetamol/ Ascorbic acid/ Caffeine/ Phenylephrine/ Chlorphenamine
300/75/30/5/2 (mg)
- Younger than 6 years: Contraindicated
- Between 6-12 years: Oral (cap): 1 cap, 3 times dly
- Older than 12 years: See adult dosage
Pregnancy & lactation
Pregnancy
South African recommendations
- Contraindicated
Breastfeeding
South African recommendations
- Caution
- Safety during lactation has not been established
Fertility
South African recommendations
- No information available
Renal impairment
South African recommendations
- Caution; no dose adjustment recommended
Patients suffering from kidney disease should take paracetamol under medical supervision
Hepatic impairment
South African recommendations
- Caution; no dose adjustment recommended
Patients suffering from liver disease should take paracetamol under medical supervision
Elderly
South African recommendations
- Caution; no information available
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Blood and the Lymphatic System Disorders
Unknown frequency
- Neutropenia
- Pancytopenia
- Leucopenia
Immune System Disorders
Unknown frequency
- Reversible skin rash
Skin and Subcutaneous Tissue Disorders
Unknown frequency
- Erythematous rash
- Urticarial rash
- Fever and mucosal lesions accompanying rash
- Fixed drug eruptions
- Drug-induced hypersensitivity syndrome
Caffeine
Nervous System Disorders
Unknown frequency
- Headache
- Insomnia
Cardiac Disorders
Unknown frequency
- Palpitations
Gastrointestinal Disorders
Unknown frequency
- Nausea
Phenylephrine
Endocrine Disorders
Unknown frequency
- Hypersalivation
Metabolism and Nutrition Disorders
Unknown frequency
- Altered metabolism including disturbance of glucose metabolism
Psychiatric Disorders
Unknown frequency
- Psychotic states
- Fear
- Anxiety
Nervous System Disorders
Unknown frequency
- Restlessness
- Tremor
- Insomnia
- Confusion
- Irritability
- Cerebral haemorrhage
- Headache
Cardiac Disorders
Unknown frequency
- Vasoconstriction
- Hypertension
- Bradycardia
- Tachycardia
- Cardiac arrhythmias
- Anginal pain
- Palpitations
- Cardiac arrest
- Hypotension with dizziness and fainting
Respiratory, Thoracic and Mediastinal Disorders
Unknown frequency
- Pulmonary oedema
- Dyspnoea
Gastrointestinal Disorders
Unknown frequency
- Nausea and vomiting
Renal and Urinary Disorders
Unknown frequency
- Difficulty in micturition
- Urinary retention
General Disorders and Administrative Site Conditions
Unknown frequency
- Weakness
- Reduced appetite
- Flushing
- Sweating
Chlorphenamine
Metabolism and Nutrition Disorders
Unknown frequency
- Anorexia
Psychiatric Disorders
Unknown frequency
- Elation
- Depression
- Nightmares
- Irritability
Nervous System Disorders
Unknown frequency
- Sedation
- Headache
- Cerebral stimulation particularly in children
- Dizziness
- Nervousness
- Tremors
- Muscle twitching
- Convulsions
Eye Disorders
Unknown frequency
- Blurred vision
Ear and Labyrinth Disorders
Unknown frequency
- Tinnitus
Cardiac Disorders
Unknown frequency
- Tightness of chest and tingling
- Hypotension
- Tachycardia
Gastrointestinal Disorders
Unknown frequency
- Nausea and vomiting
- Diarrhoea
- Constipation
- Colic
- Epigastric pain
Renal and Urinary Disorders
Unknown frequency
- Difficulty in micturition
General Disorders and Administrative Site Conditions
Unknown frequency
- Dryness of mouth
- Heaviness and weakness of hands
- Allergy and anaphylaxis
- Inability to concentrate
- Incoordination
- Lassitude
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol/ Ascorbic Acid/ Caffeine/ Phenylephrine/ Chlorphenamine
- Monoamine oxidase inhibitors
Phenylephrine
- Cyclopropane
- Halothane, or other halogenated anaesthetics
- Antihypertensives
- Cardiac glycosides
- Quinidine
- Tricyclic antidepressants
Chlorphenamine
- CNS depressants
- Barbiturates
- Hypnotics
- Narcotic analgesics
- Sedatives
- Tranquillisers
- Tricyclic antidepressants
- Guanethidine
- Reserpine
- Methyldopa
- Atropine
Monitoring
None routine. Specific cases may require
- Hepatic function
- Renal function
Mechanism of action
Paracetamol/ Ascorbic Acid/ Caffeine/ Phenylephrine/ Chlorphenamine
Paracetamol/ ascorbic acid/ caffeine/ phenylephrine/ chlorphenamine has analgesic, antipyretic, antihistaminic and decongestant properties.
Paracetamol
Paracetamol has analgesic and antipyretic actions.
Ascorbic Acid
Ascorbic acid is vitamin C.
Phenylephrine hydrochloride
Phenylephrine hydrochloride is a sympathomimetic agent.
Chlorphenamine maleate
Chlorphenamine maleate is an antihistamine.
Dosage forms
- Capsule
Formulation
COMBINATION PREPARATIONS
Paracetamol/ Ascorbic acid/ Caffeine/ Phenylephrine/ Chlorpheniramine
Capsule 300mg/75mg/30mg/5mg/2mg
- Degoran C (Novartis) originator
- Flustat (Ranbaxy)
- Grippon (Adcock)
- Sinustat flu (Litha Pharma) originator
References
1. https://drive.google.com/drive/folders/1DGCZMykrkr92PsMSKtnHNl-cc6L5YFLR (04/1994_Ranbaxy_Flustat_caps) 2. https://drive.google.com/drive/folders/1DGCZMykrkr92PsMSKtnHNl-cc6L5YFLR (07/06/2017_Mims_Grippon_caps) 3. https://drive.google.com/drive/folders/1DGCZMykrkr92PsMSKtnHNl-cc6L5YFLR (07/06/2017_Mims_Sinustat Flu) 4. Paracetamol monograph; Accessed online; 13 Nov 2018 https://cms.emguidance.com/medicine-edit/2cf8920b-6c41-40de-b3ed-65bc5778f068 5. Ascorbic acid monograph; Accessed online; 13 Nov 2018 https://cms.emguidance.com/medicine-edit/5ad999b9-bd8b-45b6-80db-931ccd94f71a 6. Caffeine monograph; Accessed online; 13 Nov 2018 https://cms.emguidance.com/medicine-edit/c6543dff-0cd0-4b30-aa88-e4e1fcbf0bb7 7. Phenylephrine monograph; Accessed online; 13 Nov 2018 https://cms.emguidance.com/medicine-edit/bb81be1c-49cd-45e9-aada-b6b48a11d4d0 8. Chlorpheniramine monograph; Accessed online; 13 Nov 2018 https://cms.emguidance.com/medicine-edit/3beb5fda-e2c7-4d47-b304-569348d9e376 9. NAPOS The Drug Database for Acute Porphyria: Paracetamol/ Ascorbic Acid/ Caffeine/ Phenylephrine/ Chlorpheniramine; Accessed online 13 Nov 2018 http://www.drugs-porphyria.org/languages/UnitedKingdom/s1.php?l=gbr 10. South African Institute for Drug-Free Sport: Flustat; Accessed online 13 Nov 2018 [http://www.drugfreesport.org.za/online-medication-check] **No SPC available 11. PI - FLUSTAT® CAPSULES, Ranbaxy Pharmaceuticals (Pty) Ltd - Date of Revision of Text 30 Sept 2023 - Downloaded online 2023 [https://pi-pil-repository.sahpra.org.za/wp-content/uploads/2023/10/pi-flustat_capsule.pdf] 12. NAPOS - The Drug Database __._Paracetamol Combinations Downloaded online 06 Nov 2023 [https://www.drugs-porphyria.org/mono.php?id=3563]
Brands & products
10 products · cached snapshot- Chlorpheniramine maleate (syn. Chlorphenamine)Degoran C
- Flustat
- Grippon
- Sinustat Flu
CAPCapsule· 10 products
from R37.20| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Sinustat Flu Capsules | 300 mg;mg;mg;mg;mg | 20 | Acino Pharma (Pty) Ltd | R37.20 |
| Sinustat Flu Capsules | 300 mg;mg;mg;mg;mg | 24 | Acino Pharma (Pty) Ltd | R44.64 |
| Endcol Cold And Flu Capsules | 300 mg;mg;mg;mg;mg | 24 | Pharmacare Limited, Woodmead | R46.55 |
| Colstat | 300 mg;mg;mg;mg;mg | 24 | LeBasi Pharmaceuticals CC | R57.87 |
| Degoran C | 300 mg;mg;mg;mg;mg | 24 | Novartis South Africa (Pty) Ltd | R71.88 |
| Grippon | 300 mg;mg;mg;mg;mg | 24 | Adcock Ingram Limited | R86.28 |
| Grippon | 300 mg;mg;mg;mg;mg | 48 | Adcock Ingram Limited | R172.56 |
| Grippon | 300 mg;mg;mg;mg;mg | 100 | Adcock Ingram Limited | R359.50 |
| Flustat Capsules | 300 mg;mg;mg;mg;mg | 1000 | Ranbaxy Pharmaceuticals (Pty) Ltd | R553.71 |
| Colstat | 300 mg;mg;mg;mg;mg | 500 | LeBasi Pharmaceuticals CC | R1206.91 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.